Insider Buying: Retractable Technologies, Inc. (NYSE:RVP) CEO Purchases 18,411 Shares of Stock

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw acquired 18,411 shares of the firm’s stock in a transaction on Monday, January 6th. The stock was bought at an average price of $0.78 per share, for a total transaction of $14,360.58. Following the completion of the acquisition, the chief executive officer now owns 14,947,978 shares of the company’s stock, valued at approximately $11,659,422.84. The trade was a 0.12 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website.

Retractable Technologies Trading Up 6.0 %

Retractable Technologies stock traded up $0.04 during trading hours on Tuesday, hitting $0.79. The stock had a trading volume of 228,180 shares, compared to its average volume of 163,173. Retractable Technologies, Inc. has a one year low of $0.56 and a one year high of $1.34. The company has a quick ratio of 5.92, a current ratio of 8.57 and a debt-to-equity ratio of 0.01. The stock has a market cap of $23.65 million, a price-to-earnings ratio of -1.46 and a beta of 1.94. The business’s 50 day simple moving average is $0.66 and its 200-day simple moving average is $0.85.

Institutional Trading of Retractable Technologies

An institutional investor recently bought a new position in Retractable Technologies stock. PFG Investments LLC purchased a new position in shares of Retractable Technologies, Inc. (NYSE:RVP) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned approximately 0.12% of Retractable Technologies at the end of the most recent quarter. 7.58% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, StockNews.com assumed coverage on Retractable Technologies in a research report on Monday. They set a “hold” rating for the company.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.